{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Lake Forest",
      "state": "IL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "74707",
      "recalling_firm": "Hospira Inc.",
      "address_1": "275 N Field Dr",
      "address_2": "N/A",
      "postal_code": "60045-2579",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Product was distributed nationwide. 23700 units distributed to US and Puerto Rico, and Bahamas was 300 units.  30 units returned by customer and destroyed internally.",
      "recall_number": "D-1500-2016",
      "product_description": "DOBUTamine Injection, USP 250 mg/20 mL, 20 mL Vial, For IV Use Only, Must be Diluted Prior to Use, (12.5 mg per mL), Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-2025-20",
      "product_quantity": "24000 vials",
      "reason_for_recall": "Discoloration: Firm received complaints of product discoloration and particulates.",
      "recall_initiation_date": "20160815",
      "center_classification_date": "20160914",
      "termination_date": "20190823",
      "report_date": "20160921",
      "code_info": "Lot #: 52175DD, Exp 01 Oct 2016",
      "more_code_info": ""
    }
  ]
}